IRIS
BABUDIERI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.225
AS - Asia 6.672
SA - Sud America 4.270
EU - Europa 4.191
AF - Africa 268
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 1
Totale 26.674
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.945
BR - Brasile 3.857
SG - Singapore 2.971
CN - Cina 1.898
UA - Ucraina 1.278
DE - Germania 727
HK - Hong Kong 669
IT - Italia 551
SE - Svezia 434
FI - Finlandia 303
VN - Vietnam 247
GB - Regno Unito 227
FR - Francia 193
AR - Argentina 132
TR - Turchia 126
CA - Canada 113
MX - Messico 104
IN - India 100
RU - Federazione Russa 99
BD - Bangladesh 92
IQ - Iraq 84
ZA - Sudafrica 82
EC - Ecuador 81
CZ - Repubblica Ceca 61
MA - Marocco 56
VE - Venezuela 55
UZ - Uzbekistan 53
AE - Emirati Arabi Uniti 51
PL - Polonia 50
PK - Pakistan 49
ES - Italia 47
JP - Giappone 47
BE - Belgio 38
CO - Colombia 37
AT - Austria 36
PY - Paraguay 36
KE - Kenya 32
ID - Indonesia 29
KR - Corea 27
NL - Olanda 27
NP - Nepal 26
AU - Australia 25
RO - Romania 23
TN - Tunisia 23
UY - Uruguay 23
PE - Perù 22
AZ - Azerbaigian 20
DZ - Algeria 20
DO - Repubblica Dominicana 19
IL - Israele 19
JO - Giordania 19
LB - Libano 16
CL - Cile 15
EG - Egitto 15
KZ - Kazakistan 15
IR - Iran 14
LT - Lituania 14
JM - Giamaica 13
KG - Kirghizistan 13
OM - Oman 13
PS - Palestinian Territory 13
SA - Arabia Saudita 13
BG - Bulgaria 12
RS - Serbia 11
EU - Europa 10
AL - Albania 9
HU - Ungheria 9
PA - Panama 9
BO - Bolivia 8
HN - Honduras 8
KW - Kuwait 8
PH - Filippine 8
SN - Senegal 7
XK - ???statistics.table.value.countryCode.XK??? 7
BY - Bielorussia 6
MK - Macedonia 6
AO - Angola 5
BN - Brunei Darussalam 5
NG - Nigeria 5
QA - Qatar 5
AM - Armenia 4
CR - Costa Rica 4
GE - Georgia 4
IE - Irlanda 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
GY - Guiana 3
LU - Lussemburgo 3
MD - Moldavia 3
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
GR - Grecia 2
ML - Mali 2
Totale 26.633
Salva come PNG Salva come JPEG
Città #
Dallas 4.071
Singapore 1.623
Chandler 1.432
Jacksonville 736
Hong Kong 664
Princeton 466
Beijing 423
Ashburn 386
Nanjing 306
New York 297
Dearborn 286
São Paulo 263
Munich 193
Wilmington 191
Los Angeles 159
Sassari 158
Shanghai 154
Boardman 146
Ann Arbor 130
Nanchang 126
Rio de Janeiro 126
Helsinki 113
Belo Horizonte 101
Shenyang 101
Ho Chi Minh City 97
Santa Clara 95
Brasília 85
Woodbridge 81
Tianjin 75
Hebei 66
Changsha 60
Curitiba 58
Hanoi 57
Brno 56
Porto Alegre 54
Campinas 51
Columbus 49
Guarulhos 47
Rome 47
Nuremberg 45
Warsaw 45
Salvador 44
Johannesburg 43
Tashkent 43
Tokyo 43
Toronto 41
Denver 40
Goiânia 40
The Dalles 40
Jiaxing 39
Montreal 39
San Francisco 39
Brussels 38
Ningbo 36
Buffalo 35
Jinan 35
Zhengzhou 35
Brooklyn 34
Council Bluffs 34
Guangzhou 34
Ribeirão Preto 34
Kunming 33
Atlanta 32
Cagliari 32
Andover 31
Norwalk 31
Chennai 30
London 30
São José dos Campos 30
Fortaleza 29
Guayaquil 29
Nairobi 29
Orem 27
Seoul 27
Sorocaba 27
Baghdad 26
Santo André 26
Stockholm 26
Chicago 25
Frankfurt am Main 25
Ankara 23
Hangzhou 23
Istanbul 23
Izmir 23
Turku 23
Dhaka 22
Houston 22
Poplar 22
Quito 22
Taizhou 22
Asunción 21
Campo Grande 21
Florianópolis 21
San Jose 21
Joinville 20
Juiz de Fora 20
Palermo 20
Amman 19
Baku 19
Boston 19
Totale 15.456
Salva come PNG Salva come JPEG
Nome #
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 261
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 257
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 252
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 204
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 199
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 197
Anaerobic bacteria and bacterial infections: perspectives on treatment and resistence in Italy 189
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 189
A case of vasculitis-like skin eruption associated with COVID-19 186
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 184
Blood born viral infections, sexually transmitted diseases and latent tuberculosis in italian prisons: a preliminary report of a large multicenter study 180
Associazione tra Tubercolosi ed infezione da HIV: programma per uno studio multicentrico 180
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 175
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 170
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 169
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 167
Application of a miniaturized system to the study of the intestinal microflora 163
Beta2-microglobulin and Neopterin: predictive markers of AIDS in HIV infection 161
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 158
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 157
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 157
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 156
A young woman with hepatitis after a sore throat 154
An outbreak of Q fever in a prison in Italy 153
Evaluation of EZH2 expression in hepatitis B patients 152
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA 152
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 148
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 147
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 147
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 147
Association of Tuberculosis risk with the degree of tubercolin reaction in HIV-infected patients 145
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 144
Dental care and HIV-infected individuals: are they equally treated? 142
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 141
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 138
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 136
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 134
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 134
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 134
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 131
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 131
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 131
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 130
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 129
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 129
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay 128
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 127
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 125
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 124
Relazione tra antigenemia ed anticorpi nell'evoluzione dell'infezione da HIV 123
An Outbreak of Q fever in a prison in Italy 122
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 121
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 120
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 119
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 119
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 118
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 118
Produzione di linee cellulari ibride per l'isolamento di virus linfotropi 118
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 117
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 117
Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature 116
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 115
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 115
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 115
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 115
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 114
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 114
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 113
Clostridi elicoidali: nuovi patogeni intestinali? Comparazione tra un ceppo umano e ceppi di provenienza animale 113
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries 113
L'attività di Imipenem contro i microrganismi anaerobi: studio policentrico su ceppi isolati da infezioni umane e confronto in vitro con altri antibiotici 113
Infectious diseases screening approach among refugees: Results from a single-center study 113
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 112
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 112
Enterococcal infections of the respiratory tract in HIV patients 111
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 111
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 111
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 111
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 111
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study 111
Diarrea associata a Clostridium spiroforme 110
Flora batterica intestinale ed organismo ospite; aspetti attuali di fisiopatologia 110
Trasmissione eterosessuale dell'infezione da HIV1 nella provincia di Sassari 110
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL) 109
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 109
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 109
Eritema cronico migrante 109
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 108
Tache Noire in a Patient with Acute Q Fever 108
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 108
HIV related aneurisms 108
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 107
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 107
HNK1 perifereal blood lymphocytes in HIV infected patients 106
Directly Observed Therapy to treat HIV Infection in Prisoners 105
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 105
Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019 105
Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients 105
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 104
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 104
Totale 13.561
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.104 0 0 0 0 0 101 218 35 310 276 121 43
2021/20221.113 170 14 7 13 10 15 41 79 89 62 134 479
2022/20232.754 278 161 68 455 299 447 23 321 466 29 113 94
2023/2024904 152 60 24 25 238 117 15 42 1 5 64 161
2024/20258.234 131 90 490 200 315 265 748 1.550 2.729 1.122 342 252
2025/20268.777 496 3.087 1.815 1.625 1.171 583 0 0 0 0 0 0
Totale 27.205